What is the equity of Dae Hwa Pharm Co this year?
Dae Hwa Pharm Co has equity of 73.23 B KRW this year.
Dae Hwa Pharm Co Equity 2024
Dae Hwa Pharm Co Equity
73.23 B KRW
Ticker
067080.KQ
ISIN
KR7067080002
In 2024, Dae Hwa Pharm Co's equity was 73.23 B KRW, a -6.1% increase from the 77.99 B KRW equity in the previous year.
Dae Hwa Pharm Co Aktienanalyse
What does Dae Hwa Pharm Co do?
Dae Hwa Pharm Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Dae Hwa Pharm Co's Equity
Dae Hwa Pharm Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Dae Hwa Pharm Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Dae Hwa Pharm Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Dae Hwa Pharm Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Dae Hwa Pharm Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Dae Hwa Pharm Co stock
What was the equity of Dae Hwa Pharm Co compared to the previous year?
The equity of Dae Hwa Pharm Co has increased/decreased by -6.1% decreased compared to the previous year.
What impact does a high equity have on investors of Dae Hwa Pharm Co?
A high equity is advantageous for investors of Dae Hwa Pharm Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Dae Hwa Pharm Co?
A low equity can be a risk for investors of Dae Hwa Pharm Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Dae Hwa Pharm Co affect the company?
An increase in equity of Dae Hwa Pharm Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Dae Hwa Pharm Co affect the company?
A reduction in equity of Dae Hwa Pharm Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Dae Hwa Pharm Co?
Some factors that can affect the equity of Dae Hwa Pharm Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Dae Hwa Pharm Co so important for investors?
The equity of Dae Hwa Pharm Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Dae Hwa Pharm Co take to change the equity?
To change equity, Dae Hwa Pharm Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Dae Hwa Pharm Co pay?
Over the past 12 months, Dae Hwa Pharm Co paid a dividend of 150 KRW . This corresponds to a dividend yield of about 1.28 %. For the coming 12 months, Dae Hwa Pharm Co is expected to pay a dividend of 150 KRW.
What is the dividend yield of Dae Hwa Pharm Co?
The current dividend yield of Dae Hwa Pharm Co is 1.28 %.
When does Dae Hwa Pharm Co pay dividends?
Dae Hwa Pharm Co pays a quarterly dividend. This is distributed in the months of January, July, January, July.
How secure is the dividend of Dae Hwa Pharm Co?
Dae Hwa Pharm Co paid dividends every year for the past 20 years.
What is the dividend of Dae Hwa Pharm Co?
For the upcoming 12 months, dividends amounting to 150 KRW are expected. This corresponds to a dividend yield of 1.28 %.
In which sector is Dae Hwa Pharm Co located?
Dae Hwa Pharm Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Dae Hwa Pharm Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Dae Hwa Pharm Co from 8/23/2024 amounting to 50 KRW, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.
When did Dae Hwa Pharm Co pay the last dividend?
The last dividend was paid out on 8/23/2024.
What was the dividend of Dae Hwa Pharm Co in the year 2023?
In the year 2023, Dae Hwa Pharm Co distributed 150 KRW as dividends.
In which currency does Dae Hwa Pharm Co pay out the dividend?
The dividends of Dae Hwa Pharm Co are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Dae Hwa Pharm Co
Our stock analysis for Dae Hwa Pharm Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dae Hwa Pharm Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Dae Hwa Pharm Co Revenue
- Dae Hwa Pharm Co Net Income
- Dae Hwa Pharm Co P/E
- Dae Hwa Pharm Co P/S
- Dae Hwa Pharm Co EBIT
- Dae Hwa Pharm Co Dividend
- Dae Hwa Pharm Co Stocks
- Dae Hwa Pharm Co Market capitalization
- Dae Hwa Pharm Co Debt
- Dae Hwa Pharm Co Liabilities
- Dae Hwa Pharm Co Equity
- Dae Hwa Pharm Co AAQS
- Dae Hwa Pharm Co Employees
- Dae Hwa Pharm Co ROE
- Dae Hwa Pharm Co ROA
- Dae Hwa Pharm Co ROCE